FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Imagawa

Research Profile

Procedures

Physiology

Living Beings

Concepts & Ideas

Chemicals & Drugs

Anatomy

Livers

Disorders

Liver Neoplasms

Co-author Network

Publications

TOP 3
Philip Y Wong; Victor Xia; John Hoefs; David K Imagawa; Ke-Qin Hu
Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans.
Maki Yamamoto; Gregg Little; David K Imagawa
Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.
clarence foster; Renee R Weng; Craig V Smith; David K Imagawa
The influence of organ acceptance criteria on long-term graft survival: outcomes of a kidney transplant program.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Imagawa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Philip Y Wong; Victor Xia; John Hoefs; David K Imagawa; Ke-Qin Hu
Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans.
Journal of immigrant and minority health / Center for Minority Public Health 2011;13(5):842-8.
2009: Maki Yamamoto; Gregg Little; David K Imagawa
Hepatitis B immunoglobulin in preventing reinfection following liver transplantation.
Expert review of anti-infective therapy 2009;7(3):321-8.
2008: clarence foster; Renee R Weng; Craig V Smith; David K Imagawa
The influence of organ acceptance criteria on long-term graft survival: outcomes of a kidney transplant program.
American journal of surgery 2008;195(2):149-52.
2005: Ming-Sing Si; Ping Ji; Michael Lee; Jennifer Kwok; Jamie Kusumoto; Eric Naasz; Shi-Chung Ng; David K Imagawa
Potent farnesyltransferase inhibitor ABT-100 abrogates acute allograft rejection.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(9):1403-9.
2003: Ming-Sing Si; Farin Amersi; S Raymond Golish; Jorge A Ortiz; Joseph Zaky; Debbie Finklestein; Ronald W Busuttil; David K Imagawa
Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival.
The American surgeon 2003;69(10):879-85.
2003: Ming-Sing Si; David K Imagawa; Ping Ji; Xunbin Wei; Bari Holm Nazario; Jennifer Kwok; Michael Lee; Bruce A Reitz; Dominic C Borie
Immunomodulatory effects of docetaxel on human lymphocytes.
Investigational new drugs 2003;21(3):281-90.
2003: Ming-Sing Si; Ping Ji; Bruce J Tromberg; Mike Lee; Jennifer Kwok; Shi-Chung Ng; David K Imagawa
Farnesyltransferase inhibition: a novel method of immunomodulation.
International immunopharmacology 2003;3(4):475-83.
2003: Yale D Podnos; Juan Carlos Jimenez; Kambiz Zainabadi; Ping Ji; Jonathon Cooke; Ronald W Busuttil; David K Imagawa
Carcinoid tumors of the common bile duct: report of two cases.
Surgery today 2003;33(7):553-5.
2002: Ping Ji; Ming-Sing Si; Yale Podnos; Helen Chow; Earl Steward; David K Imagawa
Prevention of chronic rejection by pravastatin in a rat kidney transplant model.
Transplantation 2002;74(6):821-7.
2002: P Ji; Ming-Sing Si; Yale D Podnos; David K Imagawa
Monoterpene geraniol prevents acute allograft rejection.
Transplantation proceedings 2002;34(5):1418-9.
2001: Yale D Podnos; Dmitri V Gelfand; TS Dulkanchainun; Samuel E Wilson; S Cao; P Ji; J A Ortiz; David K Imagawa
Is intraoperative cholangiography during laparoscopic cholecystectomy cost effective?
American journal of surgery 2001;182(6):663-9.
2001: Yale D Podnos; G Henry; J A Ortiz; P Ji; Jonathon Cooke; S Cao; David K Imagawa
Laparoscopic ultrasound with radiofrequency ablation in cirrhotic patients with hepatocellular carcinoma: technique and technical considerations.
The American surgeon 2001;67(12):1181-4.
2001: Melinda A Maggard; L Meng; Bibo Ke; R Allen; L Devgan; David K Imagawa
Antisense TGF-beta2 immunotherapy for hepatocellular carcinoma: treatment in a rat tumor model.
Annals of surgical oncology 2001;8(1):32-7.
2000: R Mark Ghobrial; Hasan Yersiz; Douglas G Farmer; Farin Amersi; John Goss; Pauline Chen; Sherfield Sherfield Dawson; Susan Lerner; Nicholas N Nissen; David K Imagawa; Steven D Colquhoun; W Arnout; Sue V McDiarmid; Ronald W Busuttil
Predictors of survival after In vivo split liver transplantation: analysis of 110 consecutive patients.
Annals of surgery 2000;232(3):312-23.
2000: Ming-Sing Si; David K Imagawa
Prenylation inhibitors to treat proliferative renal disease.
Lancet 2000;355(9213):1460.
2000: X Wei; Ming-Sing Si; David K Imagawa; Ping Ji; Bruce J Tromberg; M D Cahalan
Perillyl alcohol inhibits TCR-mediated [Ca(2+)](i) signaling, alters cell shape and motility, and induces apoptosis in T lymphocytes.
Cellular immunology 2000;201(1):6-13.
1999: R Mark Ghobrial; Douglas G Farmer; Angeles Baquerizo; Steven D Colquhoun; H R Rosen; Hasan Yersiz; James F Markmann; KE Drazan; Curtis Holt; David K Imagawa; Leonard I Goldstein; Paul Martin; Ronald W Busuttil
Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Annals of surgery 1999;229(6):824-31; discussion 831-3.
1999: Charles P Theuer; David K Imagawa
Use of knitted oxidized cellulose (Nu-knit) for the definitive packing of grade III liver fracture.
Injury 1999;30(2):137-40.
1999: Melinda A Maggard; C Johnson; T Wang; Paul I Terasaki; Jerzy W Kupiec-Weglinski; Ronald W Busuttil; David K Imagawa
Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response.
Transplantation proceedings 1999;31(1-2):728-9.
1998: S H Han; Milan Kinkhabwala; Paul Martin; C Holt; N Murray; Philip Seu; S Rudich; D Hiserodt; David K Imagawa; Ronald W Busuttil
Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.
The American journal of gastroenterology 1998;93(11):2245-7.
1998: JS Markowitz; Paul Martin; AJ Conrad; James F Markmann; Philip Seu; Hasan Yersiz; John A Goss; P Schmidt; A Pakrasi; L Artinian; NG Murray; David K Imagawa; Curtis Holt; Leonard I Goldstein; Risë Stribling; Ronald W Busuttil
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
Hepatology (Baltimore, Md.) 1998;28(2):585-9.
1998: TS Dulkanchainun; John A Goss; David K Imagawa; Gray D Shaw; Dean M Anselmo; Fady Kaldas; T Wang; D Zhao; A A Busuttil; Hirohisa Kato; NG Murray; Jerzy W Kupiec-Weglinski; Ronald W Busuttil
Reduction of hepatic ischemia/reperfusion injury by a soluble P-selectin glycoprotein ligand-1.
Annals of surgery 1998;227(6):832-40.
1998: R Mark Ghobrial; Steven D Colquhoun; H Rosen; P Hollis; S Ponthieux; A Pakrasi; Douglas G Farmer; J F Markman; J Markowitz; KE Drazan; Hasan Yersiz; J Singer; Risë Stribling; W Arnout; Curtis D Holt; John Goss; David K Imagawa; Philip Seu; Leonard I Goldstein; Christopher Shackleton; Paul Martin; Ronald W Busuttil
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Transplantation proceedings 1998;30(4):1470-1.
1998: Craig V Smith; David K Imagawa; Peter G Stock; Seiji Arita; S Une; T Kawahara; Yoshimasa Sakamoto; Mari Ochiai; Tetsu Nagai; Linda A Shevlin; Yoko Mullen
Simultaneous islet-liver transplantation: preliminary results from the UC Islet Transplantation Consortium.
Transplantation proceedings 1998;30(2):295-6.
1998: K M Swenson; Bibo Ke; T Wang; J S Markowitz; Melinda A Maggard; G S Spear; David K Imagawa; John A Goss; Ronald W Busuttil; Philip Seu
Fas ligand gene transfer to renal allografts in rats: effects on allograft survival.
Transplantation 1998;65(2):155-60.
1998: Melinda A Maggard; Bibo Ke; T Wang; Fady Kaldas; Philip Seu; Ronald W Busuttil; David K Imagawa
Effects of pravastatin on chronic rejection of rat cardiac allografts.
Transplantation 1998;65(2):149-55.
1998: Hugo Rosen; Paul Martin; John Goss; J Donovan; Judy Melinek; SM Rudich; David K Imagawa; Milan Kinkhabwala; Philip Seu; Ronald W Busuttil; Christopher Shackleton
Significance of early aminotransferase elevation after liver transplantation.
Transplantation 1998;65(1):68-72.
1998: SM Rudich; Milan Kinkhabwala; NG Murray; D M See; Ronald W Busuttil; David K Imagawa
Successful treatment of mycotic hepatic artery pseudoaneurysms with arterial reconstruction and liposomal amphotericin B.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1998;4(1):91-3.
1997: John A Goss; Hasan Yersiz; Christopher Shackleton; Philip Seu; Craig V Smith; JS Markowitz; Douglas G Farmer; R Mark Ghobrial; James F Markmann; WS Arnaout; David K Imagawa; Steven D Colquhoun; M H Fraiman; Sue V McDiarmid; Ronald W Busuttil
In situ splitting of the cadaveric liver for transplantation.
Transplantation 1997;64(6):871-7.
1997: J L Kakkis; Bibo Ke; Sherfield Sherfield Dawson; Melinda A Maggard; Ming-Sing Si; Fady Kaldas; W Cai; Hungyi Shau; Philip Seu; H Sauri; Ronald W Busuttil; David K Imagawa
Pravastatin increases survival and inhibits natural killer cell enhancement factor in liver transplanted rats.
The Journal of surgical research 1997;69(2):393-8.
1997: J M Millis; Judy Melinek; M Csete; David K Imagawa; K M Olthoff; G Neelankanta; Michelle Braunfeld; Michael J Sopher; S M Chan; Johnathan L Pregler; Hasan Yersiz; A A Busuttil; Christopher Shackleton; Abraham Shaked; Ronald W Busuttil
Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation.
Transplantation 1997;63(3):397-403.
1997: Curtis D Holt; Drew J Winston; Bernard M Kubak; David K Imagawa; Paul Martin; Leonard Goldstein; K Olthoff; J M Millis; Abraham Shaked; Christopher Shackleton; Ronald W Busuttil
Coccidioidomycosis in liver transplant patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(2):216-21.
1996: Kim M Olthoff; M H Rosove; Christopher Shackleton; David K Imagawa; Douglas G Farmer; P Northcross; A L Pakrasi; Paul Martin; Leonard I Goldstein; Abraham Shaked; Ronald W Busuttil
Continuous infusional 5-fluorouracil chemotherapy.
Annals of surgery 1996;224(5):686.
1996: David K Imagawa; Sherfield Sherfield Dawson; Curtis D Holt; P S Kirk; Fady Kaldas; Christopher Shackleton; Philip Seu; SM Rudich; Milan Kinkhabwala; Paul Martin; Leonard I Goldstein; N G Murray; Paul I Terasaki; Ronald W Busuttil
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
Transplantation 1996;62(7):934-42.
1996: Philip Seu; G Neelankanta; M Csete; Kim M Olthoff; SM Rudich; Milan Kinkhabwala; David K Imagawa; Leonard I Goldstein; Paul Martin; Christopher Shackleton; Ronald W Busuttil
Liver transplantation for fulminant hepatic failure in a Jehovah's Witness.
Clinical transplantation 1996;10(5):404-7.
1996: Douglas G Farmer; Abraham Shaked; Sue V McDiarmid; Kim M Olthoff; J M Millis; David K Imagawa; J O Colonna; M E Robert; K Lewin; Leonard I Goldstein; Ronald W Busuttil
Small intestine transplantation at the University of California, Los Angeles.
Transplantation proceedings 1996;28(5):2746-7.
1996: Sherfield Sherfield Dawson; David K Imagawa; C Johnson; M Cecka; Paul I Terasaki; Christopher Shackleton; Ronald W Busuttil
UCLA liver transplantation: analysis of immunological factors affecting outcome.
Artificial organs 1996;20(10):1063-72.
1996: O Jurim; Paul Martin; Drew J Winston; Christopher Shackleton; Curtis Holt; J Feller; M Csete; Abraham Shaked; David K Imagawa; Kim M Olthoff; Johnson Y N Lau; Ronald W Busuttil
Failure of ganciclovir prophylaxis to prevent allograft reinfection following orthotopic liver transplantation for chronic hepatitis B infection.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1996;2(5):370-4.
1996: John A Goss; Christopher Shackleton; KL Swenson; N L Satou; B J Nuesse; David K Imagawa; Milan Kinkhabwala; Philip Seu; JS Markowitz; SM Rudich; Sue V McDiarmid; Ronald W Busuttil
Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience.
Annals of surgery 1996;224(3):276-84; discussion 284-7.
1996: Philip Seu; Christopher Shackleton; Abraham Shaked; David K Imagawa; Kim M Olthoff; S R Rudich; Milan Kinkhabwala; Ronald W Busuttil
Improved results of liver transplantation in patients with portal vein thrombosis.
Archives of surgery (Chicago, Ill. : 1960) 1996;131(8):840-4; discussion 844-5.
1996: Philip Seu; David K Imagawa; Kim M Olthoff; Hasan Yersiz; T J Rosenthal; C A Sellers; G Ginther; M Abe; D Green; Christopher Shackleton; SM Rudich; Milan Kinkhabwala; John A Goss; JS Markowitz; Ronald W Busuttil
A prospective study on the reliability and cost effectiveness of preoperative ultrasound screening of the "marginal" liver donor.
Transplantation 1996;62(1):129-30.
1996: David K Imagawa; Kim M Olthoff; Hasan Yersiz; Christopher Shackleton; Steven D Colquhoun; Abraham Shaked; Ronald W Busuttil
Rapid en bloc technique for pancreas-liver procurement. Improved early liver function.
Transplantation 1996;61(11):1605-9.
1996: Milan Kinkhabwala; A Wilkinson; Gabriel M Danovitch; J T Rosenthal; T K Tooley; A Sanford; David K Imagawa; SM Rudich; Philip Seu; Ronald W Busuttil; Christopher Shackleton
The role of whole organ pancreas transplantation in the treatment of type I diabetes.
American journal of surgery 1996;171(5):516-20.
1996: KE Drazan; Abraham Shaked; Kim M Olthoff; David K Imagawa; O Jurim; K Kiai; C Shackelton; Ronald W Busuttil
Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT).
The American surgeon 1996;62(3):237-40.
1995: Drew J Winston; David K Imagawa; Curtis D Holt; Fady Kaldas; Abraham Shaked; Ronald W Busuttil
Long-term ganciclovir prophylaxis eliminates serious cytomegalovirus disease in liver transplant recipients receiving OKT3 therapy for rejection.
Transplantation 1995;60(11):1357-60.
1995: Hasan Yersiz; Abraham Shaked; Kim M Olthoff; David K Imagawa; Christopher Shackleton; Paul Martin; Ronald W Busuttil
Correlation between donor age and the pattern of liver graft recovery after transplantation.
Transplantation 1995;60(8):790-4.
1995: Christopher Shackleton; Paul Martin; Judy Melinek; L Stothers; J M Millis; Kim M Olthoff; David K Imagawa; Milan Kinkhabwala; SM Rudich; Philip Seu
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients.
Transplantation 1995;60(6):554-8.
1995: Stefan Moldovan; Azmi Atiya; Thomas Adrian; R M Kleinman; K C Kent Lloyd; Kim M Olthoff; David K Imagawa; Linda A Shevlin; David H Coy; J Walsh
Somatostatin inhibits B-cell secretion via a subtype-2 somatostatin receptor in the isolated perfused human pancreas.
The Journal of surgical research 1995;59(1):85-90.
1995: Douglas G Farmer; Abraham Shaked; Kim M Olthoff; David K Imagawa; J M Millis; Ronald W Busuttil
Evaluation, operative management, and outcome after liver transplantation in children with biliary atresia and situs inversus.
Annals of surgery 1995;222(1):47-50.
1995: Kim M Olthoff; M H Rosove; Christopher Shackleton; David K Imagawa; Douglas G Farmer; P Northcross; A L Pakrasi; Paul Martin; Leonard I Goldstein; Abraham Shaked
Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma.
Annals of surgery 1995;221(6):734-41; discussion 731-43.
1995: O Jurim; Christopher Shackleton; Sue V McDiarmid; Paul Martin; Abraham Shaked; J M Millis; David K Imagawa; Kim M Olthoff; A Maxfield; A L Pakrasi
Living-donor liver transplantation at UCLA.
American journal of surgery 1995;169(5):529-32.
1995: M Millis; David K Imagawa; Kim M Olthoff; Paul Martin; A Gomes; Abraham Shaked; Hasan Yersiz; KE Drazan; O Jurim; L Goldstein
TIPS: impact on liver transplantation.
Transplantation proceedings 1995;27(1):1252-3.
1995: O Jurim; M Csete; Hugh A Gelabert; J M Millis; Kim M Olthoff; David K Imagawa; Abraham Shaked; Sue V McDiarmid; R W Busuttil
Reduced-size grafts--the solution for hepatic artery thrombosis after pediatric liver transplantation?
Journal of pediatric surgery 1995;30(1):53-5.
1994: F Charles Brunicardi; Y Oh; Linda A Shevlin; E Suh; R Kleinman; E Stein; G Lipaz; D V Plant; David K Imagawa; H R Fetterman
Laser destruction of human nonislet pancreatic tissue.
Transplantation proceedings 1994;26(6):3354-5.
1994: David K Imagawa; J M Lien; M C Dugan; R K Tompkins
Angiomyolipoma of the liver presenting in pregnancy.
The American surgeon 1994;60(11):824-6.
1994: K Ogura; Paul I Terasaki; H Koyama; J Chia; David K Imagawa; Ronald W Busuttil
High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients.
Clinical transplantation 1994;8(2 Pt 1):111-5.
1994: Sherfield Sherfield Dawson; David K Imagawa; J Michael Cecka; David W Gjertson; Christopher Shackleton; Abraham Shaked; Ronald W Busuttil
UCLA liver transplantation: analysis of the first 1,000 patients.
Clinical transplants 1994;():189-95.
1993: M Shiraishi; Abraham Shaked; C Yasunaga; Y Hasuike; David K Imagawa; Ronald W Busuttil
Monoclonal anti-tumor necrosis factor-alpha antibody suppresses rejection, but enhances infectious complications in rat liver allograft recipients.
Transplantation proceedings 1993;25(1 Pt 1):128-9.
1992: David K Imagawa; K Noguchi; Y Iwaki; Ronald W Busuttil
Hyperacute rejection following ABO-compatible orthotopic liver transplantation--a case report.
Transplantation 1992;54(6):1114-7.
1992: Y Sameshima; D Chia; Paul I Terasaki; David K Imagawa; Ronald W Busuttil
Appearance of the tumor marker CA 19-9 in liver transplant patients during rejection episodes.
Transplantation 1992;53(3):580-2.
1991: Kim M Olthoff; E Wasef; Philip Seu; David K Imagawa; Julie A Freischlag; J Hart; Ronald W Busuttil
PGE1 reduces injury in hepatic allografts following preservation.
The Journal of surgical research 1991;50(6):595-601.
1991: Philip Seu; David K Imagawa; E Wasef; Kim M Olthoff; J Hart; S Stephens; R A Dempsey; Ronald W Busuttil
Monoclonal anti-tumor necrosis factor-alpha antibody treatment of rat cardiac allografts: synergism with low-dose cyclosporine and immunohistological studies.
The Journal of surgical research 1991;50(5):520-8.
1991: K Teramoto; Angeles Baquerizo; David K Imagawa; Philip Seu; J Hart; R A Dempsey; Paul I Terasaki; N Kamada; Ronald W Busuttil
Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody.
Transplantation proceedings 1991;23(1 Pt 1):602-3.
1991: Philip Seu; David K Imagawa; Kim M Olthoff; J M Millis; J Hart; E Wasef; R A Dempsey; Ronald W Busuttil
Effects of tumor necrosis factor (TNF) and immunotherapy directed against TNF on rat cardiac transplants.
Transplantation proceedings 1991;23(1 Pt 1):233-4.
1991: David K Imagawa; J M Millis; Philip Seu; Kim M Olthoff; J Hart; E Wasef; R A Dempsey; S Stephens; Ronald W Busuttil
The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.
Transplantation 1991;51(1):57-62.
1991: David K Imagawa; S M Strange; Abraham Shaked; Philip Seu; J O Colonna; Douglas G Farmer; S V McDiramid; M P Morrissey; Ronald W Busuttil
Liver transplantation at UCLA: report of clinical activities.
Clinical transplants 1991;():127-34.
1990: Angeles Baquerizo; N Kamada; J Hart; J M Millis; C Pera; Kim M Olthoff; David K Imagawa; Marshall J Orloff; Ronald W Busuttil
Influence of number and timing of serum transfusions on liver allograft survival in rats.
Transplantation proceedings 1990;22(4):2020-2.
1990: David K Imagawa; J M Millis; Kim M Olthoff; L J Derus; D Chia; L R Sugich; M Ozawa; R A Dempsey; Y Iwaki; P J Levy
The role of tumor necrosis factor in allograft rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver transplantation.
Transplantation 1990;50(2):219-25.
1990: David K Imagawa; J M Millis; Kim M Olthoff; Philip Seu; R A Dempsey; J Hart; Paul I Terasaki; E M Wasef; Ronald W Busuttil
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats.
Transplantation 1990;50(2):189-93.
1990: David K Imagawa; J M Millis; Kim M Olthoff; Philip Seu; R A Dempsey; J Hart; Paul I Terasaki; Ronald W Busuttil
Anti-tumor necrosis factor antibody enhances allograft survival in rats.
The Journal of surgical research 1990;48(4):345-8.
1990: Kim M Olthoff; J M Millis; David K Imagawa; B J Nuesse; L J Derus; J T Rosenthal; A L Milewicz; Ronald W Busuttil
Comparison of UW solution and Euro-Collins solutions for cold preservation of human liver grafts.
Transplantation 1990;49(2):284-90.
1988: J M Millis; Kim M Olthoff; David K Imagawa; Angeles Baquerizo; Ronald W Busuttil
Liver transplantation at UCLA: a report of clinical activities.
Clinical transplants 1988;():29-34.